Does growth factor support treat febrile neutropenia?

Febrile neutropenia combines a fever with a low level of neutrophils, white blood cells that help fight bacterial and fungal infections. It can develop during cancer treatment and may worsen quickly, even when the source of infection is not obvious. A growth factor can stimulate the bone marrow to produce neutrophils, but its effect takes time. Clinicians decide whether it is appropriate by considering the infection, blood counts, treatment history, and overall condition.

Treat a suspected episode as urgent: contact your oncology team or attend the advised emergency service immediately. Medical staff may check blood counts, cultures, vital signs, and possible infection sites, then give antimicrobial treatment when indicated. Growth factor support may be added for selected higher-risk situations. Do not wait for an injection to work before seeking assessment, and do not self-administer a dose unless it was prescribed for this episode.

Seek emergency advice for a fever after chemotherapy or for chills, shaking, confusion, dizziness, breathing difficulty, severe weakness, new pain, or a catheter-site change. Tell staff when your last treatment occurred and whether you have been using growth factor support. Use the emergency temperature instructions supplied by your cancer team, because thresholds and plans can differ between patients.

Would growth factor support help in my specific risk situation? Which antimicrobial plan should I follow if fever returns? When should my blood count be checked again?